ReviewFrontiers in immunology2025
Transient receptor potential channels as key regulators of cell death in atherosclerosis.
Review in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cell-Surface Signatures and Targets of Modulated Vascular Smooth Muscle Cells in Atherosclerosis: From State Identification to Precision Intervention.Journal of cardiovascular development and disease · 2026Review
- Review
- Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis.Basic research in cardiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transient receptor potential (TRP) channels are non-selective cation channels with diverse physiological functions, widely expressed across various cell types. These channels play crucial roles in maintaining homeostasis and contribute to the progression of cardiovascular diseases, particularly atherosclerosis. Atherosclerosis is a chronic vascular inflammatory condition marked by lipid accumulation and fibrous tissue proliferation in the arterial intima. TRP channels regulate intracellular ionic gradients and activate downstream signaling pathways, thereby influencing the function of vascular endothelial and smooth muscle cells. Therefore, they are increasingly implicated in the pathogenesis of cardiovascular and cerebrovascular diseases. Emerging evidence has demonstrated that pharmacological modulation (antagonism or activation) of TRP channels regulates programmed cell death mechanisms, positioning these channels as key modulators of atherosclerotic plaque dynamics. Specifically, TRP channels modulate various cell death modalities, including apoptosis, autophagy, and necrosis, while also influencing inflammatory responses and oxidative stress-related pathways that potentiate cellular death. These interconnected mechanisms significantly contribute to the development of atherosclerotic lesions. This review systematically examined the mechanistic roles of TRP channels in atherosclerosis via regulation of cell death pathways, aiming to provide a comprehensive understanding of their pathophysiological functions and to support the development of targeted molecular therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.